Regulation of glutamate release by α7 nicotinic receptors: Differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 900-907

  Northrop, Nicole A ^a,b   Smith, Laura P ^b   Yamamoto, Bryan K ^b   Eyerman, David J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; DOPAMINE; DOPAMINE TRANSPORTER; GLUTAMIC ACID; METHAMPHETAMINE; METHYLLYCACONITINE; SEROTONIN; SEROTONIN TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HYPERTHERMIA; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; DOPAMINE; GLUTAMIC ACID; MALE; METHAMPHETAMINE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SEROTONIN;

EID: 79951960898     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.177287     Document Type: Article

References (40)

1. Abekawa T, Ohmori T, and Koyama T (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643:276-281. (Pubitemid 24115101)
2. Bhardwaj A, Northington FJ, Ichord RN, Hanley DF, Traystman RJ, and Koehler RC (1997) Characterization of ionotropic glutamate receptor-mediated nitric oxide production in vivo in rats. Stroke 28:850-856; discussion 856-857.
3. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, and Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
4. Burrows KB, Nixdorf WL, and Yamamoto BK (2000) Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. J Pharmacol Exp Ther 292:853-860. (Pubitemid 30136575)
5. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
6. Crawshaw LI (1973) Effect of intracranial acetylcholine injection on thermoregulatory responses in the rat. J Comp Physiol Psychol 83:32-35.
7. Escubedo E, Chipana C, Pérez-Sánchez M, Camarasa J, and Pubill D (2005) Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of α7 nicotinic receptors. J Pharmacol Exp Ther 315:658-667. (Pubitemid 41500731)
8. Eyerman DJ and Yamamoto BK (2007) A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 103:1219-1227. (Pubitemid 47568738)
9. Frey K, Kilbourn M, and Robinson T (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 334:273-279. (Pubitemid 27451998)
10. Garcia-Ratés S, Camarasa J, Escubedo E, and Pubill D (2007) Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation. Toxicol Appl Pharmacol 223:195-205. (Pubitemid 47362216)
11. Haughey HM, Fleckenstein AE, Metzger RR, and Hanson GR (2000) The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia. J Neurochem 75:1608-1617.
12. Hernández LF, Segovia G, and Mora F (2003) Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study. Neurochem Res 28:1819-1827. (Pubitemid 37444678)
13. Hirata H, Ladenheim B, Rothman RB, Epstein C, and Cadet JL (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res 677:345-347.
14. Hotchkiss AJ and Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262. (Pubitemid 10049032)
15. Konradsson-Geuken A, Gash CR, Alexander K, Pomerleau F, Huettl P, Gerhardt GA, and Bruno JP (2009) Second-by-second analysis of α7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats. Synapse 63:1069-1082.
16. Kuhn DM and Geddes TJ (1999) Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J Biol Chem 274:29726-29732.
17. LaVoie MJ and Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491. (Pubitemid 29088929)
18. Li Y, Meyer EM, Walker DW, Millard WJ, He YJ, and King MA (2002) Alpha7 nicotinic receptor activation inhibits ethanol-induced mitochondrial dysfunction, cytochrome c release and neurotoxicity in primary rat hippocampal neuronal cultures. J Neurochem 81:853-858. (Pubitemid 34809313)
19. Marchi M, Risso F, Viola C, Cavazzani P, and Raiteri M (2002) Direct evidence that release-stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80:1071-1078. (Pubitemid 34809959)
20. Nash JF and Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
21. Noda M, Nakanishi H, Nabekura J, and Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20:251-258. (Pubitemid 30220512)
22. Orio L, Llopis N, Torres E, Izco M, O'Shea E, and Colado MI (2010) A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons. Neurotox Res 18:187-199.
23. Park SU, Ferrer JV, Javitch JA, and Kuhn DM (2002) Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J Neurosci 22:4399-4405. (Pubitemid 37465656)
24. Pubill D, Chipana C, Camins A, Pallàs M, Camarasa J, and Escubedo E (2005) Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol Appl Pharmacol 204:57-68.
25. Ricaurte GA, Schuster CR, and Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153-163. (Pubitemid 10120970)
26. Ryan RE, Ross SA, Drago J, and Loiacono RE (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132: 1650-1656. (Pubitemid 32397956)
27. Sadidi M, Geddes TJ, and Kuhn DM (2005) S-thiolation of tyrosine hydroxylase by reactive nitrogen species in the presence of cysteine or glutathione. Antioxid Redox Signal 7:863-869. (Pubitemid 40967137)
28. Sandoval V, Riddle EL, Hanson GR, and Fleckenstein AE (2003) Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. J Pharmacol Exp Ther 304:1181-1187. (Pubitemid 36254431)
29. Segovia G, Del Arco A, and Mora F (1997) Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem 69:1476-1483. (Pubitemid 27406948)
30. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, and Patrick JW (1993) Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604. (Pubitemid 23045143)
31. Siman R and Noszek JC (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287.
32. Staszewski RD and Yamamoto BK (2006) Methamphetamine-induced spectrin proteolysis in the rat striatum. J Neurochem 96:1267-1276.
33. Storey E, Hyman BT, Jenkins B, Brouillet E, Miller JM, Rosen BR, and Beal MF (1992) 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J Neurochem 58:1975-1978.
34. Taguchi K, Atobe J, Kato M, Chuma T, Chikuma T, Shigenaga T, and Miyatake T (1998) The effect of methamphetamine on the release of acetylcholine in the rat striatum. Eur J Pharmacol 360:131-137. (Pubitemid 28529179)
35. Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, and Kuhn DM (2004) Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 367:349-354. (Pubitemid 39178611)
36. Turek JW, Kang CH, Campbell JE, Arneric SP, and Sullivan JP (1995) A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61:113-118.
37. Wolf ME (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
38. Wonnacott S, Kaiser S, Mogg A, Soliakov L, and Jones IW (2000) Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur J Pharmacol 393:51-58. (Pubitemid 30193400)
39. Xiao Y, Abdrakhmanova GR, Baydyuk M, Hernandez S, and Kellar KJ (2009) Rat neuronal nicotinic acetylcholine receptors containing α7 subunit: pharmacological properties of ligand binding and function. Acta Pharmacol Sin 30:842-850.
40. Yamamoto BK and Pehek EA (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res 506:236-242. (Pubitemid 20031603)